PULSE BIOSCIENCES, INC. — Director's Dealing 2024

May 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2024-05-20

Reporting Person: Barrett Burke Thomas (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-20	Common Stock	P	10000	$8.56	Acquired	10000	Direct

Footnotes

F1: Volume-weighted average price.